Denis Bigg

Title: Denis Bigg: Innovator in Pharmaceutical Chemistry

Introduction

Denis Bigg is a notable inventor based in Jouy en Josas, France. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds with potential therapeutic applications. His work has led to the creation of innovative chemical derivatives that may have important implications in medicine.

Latest Patents

Denis Bigg holds a patent for a compound titled "2-(4,5-Dihydro-1H-imidazol-2-yl)-2,3-dihydroindole derivatives and their derivatives of formula (I)." This patent describes a range of chemical structures where X can denote various atoms or radicals, and R can represent different alkyl or aryl groups. The compounds are noted for their potential as alpha-2 receptor antagonists, which could be beneficial in various therapeutic contexts. He has 1 patent to his name.

Career Highlights

Denis Bigg has been associated with Synthelabo, a company known for its focus on pharmaceutical research and development. His work at Synthelabo has allowed him to explore innovative solutions in drug development, contributing to advancements in the industry.

Collaborations

Throughout his career, Denis has collaborated with esteemed colleagues such as Jean Pierre Merly and Christian Maloizel. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical chemistry.

Conclusion

Denis Bigg's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in therapeutic compounds.